{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Nevro Corp."},"Symbol":{"label":"Symbol","value":"NVRO"},"Address":{"label":"Address","value":"1800 BRIDGE PARKWAY, REDWOOD CITY, California, 94065, United States"},"Phone":{"label":"Phone","value":"+1 650 251-0005"},"Industry":{"label":"Industry","value":"Medical/Dental Instruments"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States. It also receives nearly half of its revenue from Australia, the United Kingdom, and Germany."},"CompanyUrl":{"label":"Company Url","value":"https://www.nevro.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Christopher Christoforou","title":"Chief Operating Officer"},{"name":"David Caraway","title":"Chief Medical Officer & Senior Vice President"},{"name":"Donald A. Middlebrook","title":"Senior VP-Clinical, Regulatory & Quality"},{"name":"Kerry Bradley","title":"Vice President-Scientific Affairs"},{"name":"Kevin R. Thornal","title":"President, Chief Executive Officer & Director"},{"name":"Rebecca Palbicki","title":"Vice President-Information Technology"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}